Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Journal of Endocrinological Investigation
|
October 21, 2010
Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome
M Rizzo, R A Longo, E Guastella, et al.
La Clinica Terapeutica
|
February 28, 1979
[Use of cyproheptadine in the treatment of Cushing's disease]
A Jannì, E Carmina, P Lanzara, et al.
American Journal of Obstetrics and Gynecology
|
December 1, 1991
Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?
F Z Stanczyk, L Chang, E Carmina, et al.
La Clinica Terapeutica
|
August 15, 1977
[Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment]
A Jannì, E Carmina, P Lanzara, et al.
American Journal of Obstetrics and Gynecology
|
December 1, 1992
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?
E Carmina, T Koyama, L Chang, et al.
Archivio Per Le Scienze Mediche
|
July 1, 1979
[Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine]
E Carmina, P Lanzara, R Lo Coco, et al.
European Journal of Endocrinology
|
December 31, 2005
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS
E Carmina, N Napoli, R A Longo, et al.
Fertility and Sterility
|
July 1, 1992
The ratio of androstenedione:11 beta-hydroxyandrostenedione is an important marker of adrenal androgen excess in women
E Carmina, F Z Stanczyk, L Chang, et al.
Acta Endocrinologica
|
January 1, 1984
Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern
E Carmina, F Rosato, M Maggiore, et al.
Fertility and Sterility
|
October 1, 1994
Alterations in androgen conjugate levels in women and men with alopecia
R S Legro, E Carmina, F Z Stanczyk, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Journal of Endocrinological Investigation
|
October 21, 2010
Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome
M Rizzo, R A Longo, E Guastella, et al.
La Clinica Terapeutica
|
February 28, 1979
[Use of cyproheptadine in the treatment of Cushing's disease]
A Jannì, E Carmina, P Lanzara, et al.
American Journal of Obstetrics and Gynecology
|
December 1, 1991
Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?
F Z Stanczyk, L Chang, E Carmina, et al.
La Clinica Terapeutica
|
August 15, 1977
[Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment]
A Jannì, E Carmina, P Lanzara, et al.
American Journal of Obstetrics and Gynecology
|
December 1, 1992
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?
E Carmina, T Koyama, L Chang, et al.
Archivio Per Le Scienze Mediche
|
July 1, 1979
[Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine]
E Carmina, P Lanzara, R Lo Coco, et al.
European Journal of Endocrinology
|
December 31, 2005
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS
E Carmina, N Napoli, R A Longo, et al.
Fertility and Sterility
|
July 1, 1992
The ratio of androstenedione:11 beta-hydroxyandrostenedione is an important marker of adrenal androgen excess in women
E Carmina, F Z Stanczyk, L Chang, et al.
Acta Endocrinologica
|
January 1, 1984
Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern
E Carmina, F Rosato, M Maggiore, et al.
Fertility and Sterility
|
October 1, 1994
Alterations in androgen conjugate levels in women and men with alopecia
R S Legro, E Carmina, F Z Stanczyk, et al.
Page
of 9